Rumors are circulating that Gilead is looking at acquiring Galapagos stock. The source of the rumors appears to be coming from this article.
Galapagos stock could be an attractive acquisition target for Gilead. The two companies already have an existing relationship with filgotinib. Recently Galapagos exercised a co-promotion option with Gilead, sharing profits in a number of countries inside and outside of Europe. Gilead may just decide it wants the whole company. Why?
Author: Lance Jepsen
For ethical purposes, I try not to hold any position in any stock I profile on GuerillaStockTrading.com unless specifically stated in the article. Owner of GuerillaStockTrading.com. Seasoned entrepreneur, investor, and writer. I love God, family, country, stock trading, economics, and helping people learn how to trade. View all posts by Lance Jepsen